Navigation Links
MedApps Receives FDA Clearance on a New Way to Bring Cost-Effective Remote Health Monitoring to More People
Date:6/9/2009

MedApps' Innovative Personal Health Device: A Key to Lowering Healthcare Costs and Expanding Viability and Adoption of Electronic Health Records

SCOTTSDALE, Ariz., June 9 /PRNewswire/ -- Health professionals and patients alike have access to a new set of tools that will aid in stabilizing mounting healthcare costs by increasing compliance. MedApps, Inc. has been granted a 510(k) market clearance by the U.S. Food and Drug Administration for its expanded, flexible telehealth solution.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090609/LA28821 )

The MedApps system is designed to link patients, families and healthcare professionals by providing a convenient way to remotely collect, transmit, store and report timely and accurate health information -- anywhere.

The MedApps system features the HealthPAL, a small portable personal health device, to collect and transmit readings from glucose meters, blood pressure monitors, weight scales and pulse oximeters. Timely health readings from these devices are useful in maintaining wellness regimens and can assist clinicians in their treatment of patients with chronic diseases. The collected data is automatically transmitted to a secure central server where it can be accessed by healthcare professionals or stored to an online electronic personal health record such as Microsoft(R) HealthVault(TM) or Google(TM) Health.

HealthPAL is simple to use and ready to go "out of the box". It eliminates the need for specialized hardware, expensive cellular plans, or computers to collect and transmit biometric readings. The ease of use is a key factor in improving patient compliance. Initial results from pilot programs using the MedApps solution, including those in place with Cleveland Clinic and Baptist Home Health Network, have been very encouraging.

"Our entire system is designed around a single criterion -- increasing patient compliance," said Kent Dicks, MedApps Founder & CEO. "Patient compliance is greatly dependent on simplicity, and simplicity helps drive costs down and reliability up. It's key in keeping patients engaged and healthcare costs in check, and it's no coincidence that we have significantly improved patient compliance in all of our pilots."

The MedApps system offers healthcare professionals the opportunity to monitor patient conditions and manage diseases at earlier stages when associated expenses are lower. Additionally, the system provides patients with more user friendly tools, which enables them to take a more active role in their own health management.

About MedApps

MedApps is dedicated to providing innovative solutions for the collection, transmission and management of remote-monitored patient data. The company is recognized as a telehealth industry leader, winning the Nokia MobileRules Competition, as well as receiving the Frost & Sullivan North American Technology Innovation Award for Wireless Point of Care and being selected a finalist of the Dell / NFIB Excellence Award. www.medapps.com

    Media Contact:
    Randy Strength
    MedApps, Inc.
    (480) 305-6323
    Randy.strength@medapps.net


'/>"/>
SOURCE MedApps
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedApps HealthPAL Connects to Microsoft HealthVault to Improve Patient Compliance and Lower Healthcare Costs
2. MedApps Wins Nokia 2008 Mobile Rules! Business Plan Competition Award
3. MedApps Receives Prestigious Frost & Sullivan Award
4. Cardiatis Multilayer Aneurysm Repair System, MARS, Receives CE Mark Approval for Treating Peripheral Aneurysms
5. Palomar Receives FDA Over-The-Counter Clearance for a Home Use Wrinkle Removal Laser Device
6. Loyola fellow receives Amgen grant to study treatments for older leukemia patients
7. XTENT, Inc. Receives Conditional Approval for Investigational Device Exemption of Custom NX(R) Drug Eluting Stent System from United States Food and Drug Administration
8. Cepheid Receives Health Canada License for Xpert(R) HemosIL(R) FII & FV Test
9. Innovia Receives FDA Clearance For The InnoPort(TM)
10. Cordex Receives Special Protocol Assessment Approval from FDA for ATPace(TM)
11. Respected Surgeon Receives Emmy Nomination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... the first technology to directly address the resolution to globally reduce the harmful ... a patented compound of FDA and TTB approved ingredients that when infused into ...
(Date:3/28/2017)... ... March 28, 2017 , ... Resoundant, Inc., the developer of ... Siemens Healthineers annual customer education symposium, a world-class learning conference that offers educational ... 27 - 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , ...
(Date:3/28/2017)... ... March 29, 2017 , ... The Thyroid Secret is a ... FASCP. The program was recently launched on March 1, and Dr. Wentz discussed ... , Dr. Izabella Wentz is a licensed pharmacist and a foremost thyroid ...
(Date:3/28/2017)... Seattle, WA (PRWEB) , ... March 28, 2017 ... ... reach a 22% share of all holidays (IBT World Travel Trends Report). As ... physically challenging, include a range in temperatures, and prolonged sun exposure. In response, ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... advancing the science and clinical practice of radiosurgery, announced today the publication ... multi-institutional, observational registry established to standardize data collection from patients treated with ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... 2017 The global emerging cancer diagnostics market ... from 2016 to 2023 and reach a figure of ... is a chronic disease and is affecting a huge ... market. This report is focused on emerging cancer diagnostics ... is propelled due to factors such as: increasing number ...
(Date:3/28/2017)... 2017  Medeon Biodesign, Inc., a ... to announce that the Company led and successfully ... Inc., a San Jose, CA ... orthopedic extremity applications.  The orthopedic ... due to procedure volume growth, lifestyle influences and ...
(Date:3/28/2017)... -- "US Cancer Generics Market Outlook 2022" report gives ... analysis related to the emergence and integration of ... US. The report analyzes various clinical and non-clinical ... drugs in recent years. The introduction of generics ... for various stake holders involved US cancer drug ...
Breaking Medicine Technology: